Identification of Medically Actionable Secondary Findings in the 1000 Genomes.
The American College of Medical Genetics and Genomics (ACMG) recommends that clinical sequencing laboratories return secondary findings in 56 genes associated with medically actionable conditions. Our goal was to apply a systematic, stringent approach consistent with clinical standards to estimate the prevalence of pathogenic variants associated with such conditions using a diverse sequencing reference sample. Candidate variants in the 56 ACMG genes were selected from Phase 1 of the 1000 Genomes dataset, which contains sequencing information on 1,092 unrelated individuals from across the world. These variants were filtered using the Human Gene Mutation Database (HGMD) Professional version and defined parameters, appraised through literature review, and examined by a clinical laboratory specialist and expert physician. Over 70,000 genetic variants were extracted from the 56 genes, and filtering identified 237 variants annotated as disease causing by HGMD Professional. Literature review and expert evaluation determined that 7 of these variants were pathogenic or likely pathogenic. Furthermore, 5 additional truncating variants not listed as disease causing in HGMD Professional were identified as likely pathogenic. These 12 secondary findings are associated with diseases that could inform medical follow-up, including cancer predisposition syndromes, cardiac conditions, and familial hypercholesterolemia. The majority of the identified medically actionable findings were in individuals from the European (5/379) and Americas (4/181) ancestry groups, with fewer findings in Asian (2/286) and African (1/246) ancestry groups. Our results suggest that medically relevant secondary findings can be identified in approximately 1% (12/1092) of individuals in a diverse reference sample. As clinical sequencing laboratories continue to implement the ACMG recommendations, our results highlight that at least a small number of potentially important secondary findings can be selected for return. Our results also confirm that understudied populations will not reap proportionate benefits of genomic medicine, highlighting the need for continued research efforts on genetic diseases in these populations.
Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America.
Emily
E
Olfson
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Genetics, Washington University School of Medicine, St Louis, Missouri, United States of America.
Catherine E
CE
Cottrell
Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.
Nicholas O
NO
Davidson
Department of Neurology, Washington University School of Medicine, St Louis, Missouri, United States of America.
Christina A
CA
Gurnett
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America.
Jonathan W
JW
Heusel
Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America; Division of Statistical Genomics, Washington University School of Medicine, St Louis, Missouri, United States of America.
Nathan O
NO
Stitziel
Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America.
Li-Shiun
LS
Chen
Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America.
Sarah
S
Hartz
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America; Department of Genetics, Washington University School of Medicine, St Louis, Missouri, United States of America; Chief Informatics Officer, Pierian DX, St Louis, Missouri, United States of America.
Rakesh
R
Nagarajan
Department of Genetics, Washington University School of Medicine, St Louis, Missouri, United States of America.
Nancy L
NL
Saccone
Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, United States of America.
Laura J
LJ
Bierut
D030541:Databases, Genetic; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D014644:Genetic Variation; D015894:Genome, Human; D023281:Genomics / Q000379:methods*; D006801:Humans; D009154:Mutation